Home » Topics » Conferences

Conferences
RSS

First clinical results reported for novel gene therapy in coronary artery disease

Nov. 12, 1998

SPBN: a free radical scavenger with potential in pediatric head trauma

Nov. 12, 1998

NK2 antagonist from Zeneca blocks increased pulmonary resistance in guinea pigs

Nov. 12, 1998

New mechanism of action described for immunomodulating agent OM-89

Nov. 12, 1998

ETA antagonist has positive effects on pulmonary vascular resistance in patients with HF

Nov. 12, 1998

KGF-2 shows promise for treating IBD

Nov. 12, 1998

Team from Angiotech demonstrates paclitaxel's potential as an antipsoriatic

Nov. 12, 1998

S-18127 characterized as a selective, structurally novel 5-HT1B/1D receptor antagonist

Nov. 12, 1998

Levosimendan clinical results presented this week at AHA meeting

Nov. 12, 1998

Radiopharmaceutical for chronic knee synovitis in development at British university

Nov. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...